Literature DB >> 1171391

Familial poliodystrophy, mitochondrial myopathy, and lactate acidemia.

Y Shapira, S D Cederbaum, P A Cancilla, D Nielsen, B M Lippe.   

Abstract

In two siblings with limb-girdle muscle weakness and episodic headaches and vomiting from early childhood, progressive neurologic degeneration later developed, and both children died. In one child, corticosteroids induced improvement in both cerebral and muscular symptoms that lasted 1 year. This patient had elevated blood, urine, and spinal fluid lactate levels, together with increased cardiac output and oxygen consumption at rest. Several muscle fibers were characterized by a "ragged red" appearance with the trichrome stain. Subsarcolemmal and intermyofibrillar excess of mitochondrial oxidative enzyme reaction product was correlated with abnormal mitochondrial aggregates by electron microscopy. The brain revealed focal areas of cortical degeneration and necrosis with adjacent gliosis or edema. Ferrocalcific deposits were prominent in the globus pallidus. The other sibling had similar changes in the brain at autopsy. This familial multisystem disorder especially involving the brain, skeletal muscle, and heart appears to represent a defect in some mitochondrial oxidative mechanism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171391     DOI: 10.1212/wnl.25.7.614

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  26 in total

1.  Involvement of extraocular muscle in mitochondrial encephalomyopathy.

Authors:  S Takeda; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study.

Authors:  K Mizukami; M Sasaki; T Suzuki; H Shiraishi; J Koizumi; N Ohkoshi; T Ogata; N Mori; S Ban; K Kosaka
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

3.  The mitochondrial A3243G mutation presenting as severe cardiomyopathy.

Authors:  L Vilarinho; F M Santorelli; M J Rosas; C Tavares; M Melo-Pires; S DiMauro
Journal:  J Med Genet       Date:  1997-07       Impact factor: 6.318

4.  Glucocorticoids for mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-02       Impact factor: 1.858

Review 5.  Mitochondrial myopathy: a genetic study of 71 cases.

Authors:  A E Harding; R K Petty; J A Morgan-Hughes
Journal:  J Med Genet       Date:  1988-08       Impact factor: 6.318

Review 6.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  Dyssynergia cerebellaris myoclonica (Ramsay Hunt syndrome): a condition unrelated to mitochondrial encephalomyopathies.

Authors:  C A Tassinari; R Michelucci; P Genton; J F Pellissier; J Roger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

8.  Multiple sclerosis and mitochondrial myopathy: an unusual combination of diseases.

Authors:  L Bet; M Moggio; G P Comi; C Mariani; A Prelle; N Checcarelli; A Bordoni; N Bresolin; E Scarpini; G Scarlato
Journal:  J Neurol       Date:  1994-07       Impact factor: 4.849

9.  Mitochondrial encephalomyopathy. A variant with heart failure and liver steatosis.

Authors:  A Oldfors; M Tulinius; E Holme; H Kalimo; B Kristiansson; B O Eriksson
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

10.  Mitochondrial angiopathy in cerebral blood vessels of mitochondrial encephalomyopathy.

Authors:  E Ohama; S Ohara; F Ikuta; K Tanaka; M Nishizawa; T Miyatake
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.